Log In Sign Up

Trading

Trading

Browse Companies

Data

Data

IPO Stock Tracker

Solutions

Solutions

For Shareholders

For Institutions

Insights

Insights

Popular Topics

Buying Pre-IPO Shares

Selling Pre-IPO Shares

Private Market Reports

Private Market Data & Analytics

About

About

Investor Relations

People & Culture

Twin Stock

twinhealth.comHealthcareFounded: 2018Funding to Date: $186.15MM

Twin focuses on healthcare solutions to reverse and prevent chronic metabolic diseases.

Buy or sell Twin stock Learn more about Twin IPO

Overview Financings Valuation

Enterprise Value (based on primary financings)

Enterprise Value

View Enterprise Value for Twin.

Register Today

Twin investors also invested in these private companies

Sequoia Capital India

Razorpay, Biofourmis, Eruditus, Freshworks, Akulaku, Twin, Insider, Tabby

ICONIQ Growth

Relativity Space, Epic Games, BetterUp, Intercom, Drata, Articulate, Gem, Twin, Virtru

DAG Ventures

Harvest Power, Taulia, Wealthfront, Lithium Technologies, uShip, Twin

Corner Ventures

Instawork, Twin

Next Play Ventures

Varo, Nightfall AI, Exabeam, Multiverse, LogicGate, Twin

Team

Management Team

Jahangir Mohammed

Co-Founder, Chief Executive Officer & Board Member

Garrick Bernstein

Chief Financial Officer

Terrence Poon

Co-Founder & Chief Technology Officer

John Davis

Chief Commercial Officer

Maluk Mohamed Ph.D

Co-Founder, Vice President of Research & Board Member

Lisa Shah MD

Chief Medical Officer

Christine Purcell

Chief Marketing Officer

Board Members

Caroline Xie

Board Member

Mohit Bhatnagar

Board Member

Toby Cosgrove MD

Board Member

Other companies like Twin in the Healthcare sector

Sector

Last Round Est. Valuation

$2.15B

Sector

Last Round Est. Valuation

$3.67B

Pendulum Therapeutics

Sector

Last Round Est. Valuation

$303.94MM

Sector

Last Round Est. Valuation

$298.33MM

Mammoth Biosciences

Sector

Last Round Est. Valuation

$1.08B

Sector

Sector

Last Round Est. Valuation

$334.19MM

Sector

Last Round Est. Valuation

$4.26B

Biosplice Therapeutics

Sector

Frequently Asked Questions